Taro to market Suven's head lice treatment in the US, other markets
This article was originally published in Scrip
Executive Summary
Taro Pharmaceutical Industries' North American arm is to market and distribute Suven Life Sciences' head lice treatment, malathion lotion 0.5% w/v, in the US, Canada and Mexico.